{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:28:31Z","timestamp":1793212111156,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd000067.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T00:00:00Z","timestamp":1446163200000}}],"reference-count":79,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000067.pub3","type":"journal-article","created":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T19:10:40Z","timestamp":1446232240000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease"],"prefix":"10.1002","volume":"2016","author":[{"given":"Nilesh","family":"Chande","sequence":"first","affiliation":[{"name":"London Health Sciences Centre - Victoria Hospital; Room E6-321A 800 Commissioners Road East London ON Canada N6A 5W9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petrease H","family":"Patton","sequence":"additional","affiliation":[{"name":"University of Western Ontario; Schulich School of Medicine & Dentistry; London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Tsoulis","sequence":"additional","affiliation":[{"name":"Robarts Research Institute; Robarts Clinical Trials; P.O. Box 5015 100 Perth Drive London ON Canada N6A 5K8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benson S","family":"Thomas","sequence":"additional","affiliation":[{"name":"University of Western Ontario; Department of Medicine; London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K","family":"MacDonald","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials; Cochrane IBD Group; 100 Dundas Street, Suite 200 London ON Canada N6A 5B6"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,10,30]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD000067.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/gut.37.5.674","article-title":"A controlled double blind study of azathioprine in the management of Crohn's disease","volume":"37","author":"Candy","year":"1995","journal-title":"Gut"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0002|cit2","first-page":"A659","article-title":"A double blind controlled study of azathioprine in the treatment and maintenance of remission in Crohn's disease [abstract]","volume":"106","author":"Candy","year":"1994","journal-title":"Gastroenterology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD000067.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/S0016-5085(12)60608-8","article-title":"Accelerated step-care therapy with early azathioprine (AZA) vs. conventional step-care therapy in Crohn's disease: a randomized study","volume":"142","author":"Cosnes","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD000067.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"758-65.e2; quiz","DOI":"10.1053\/j.gastro.2013.04.048","article-title":"Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial","volume":"145","author":"Cosnes","year":"2013","journal-title":"Gastroenterology"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD000067.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"A196","DOI":"10.1016\/S0016-5085(03)80985-X","article-title":"Endoscopic healing of Crohn's ileo-colitis with azathioprine","volume":"124","author":"Colombel","year":"2003","journal-title":"Gastroenterology"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD000067.pub3-BIB0007|cit6","first-page":"A23","article-title":"Randomized, double-blind, placebo-controlled, multicenter, azathioprine (AZA) withdrawal trial in Crohn\u2019s disease (CD)","volume":"122","author":"Lemann","year":"2002","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD000067.pub3-BIB0006|cit7","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1053\/j.gastro.2005.03.031","article-title":"A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine","volume":"128","author":"L\u00e9mann","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0008|cit8","first-page":"A54","article-title":"A prospective, randomized trial of infliximab and azathioprine for the induction and maintenance of remission of steroid-dependent Crohn's disease","volume":"126","author":"Mantzaris","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ibd.20777","article-title":"Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease","volume":"15","author":"Mantzaris","year":"2009","journal-title":"Inflammtory Bowel Diseases"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD000067.pub3-BIB0010|cit10","first-page":"A81","article-title":"Maintenance therapy with azathioprine is superior to budesonide in healing endoscopic lesions and improving histology in clinically quiescent Crohn's disease","volume":"122","author":"Mantzaris","year":"2002","journal-title":"Gastroenterology"},{"issue":"Suppl V","key":"10.1002\/14651858.CD000067.pub3-BIB0011|cit11","first-page":"A132","article-title":"Methotrexate and 6-mercaptopurine in steroid-dependent inflammatory bowel disease patients: A randomized controlled clinical trial","volume":"45","author":"Hermida","year":"1999","journal-title":"Gut"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/00042737-200012110-00010","article-title":"6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease","volume":"12","author":"Mat\u00e9-Jim\u00e9nez","year":"2000","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"5 II","key":"10.1002\/14651858.CD000067.pub3-BIB0014|cit13","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/0016-5085(78)93543-6","article-title":"Azathioprine as a maintenance treatment for Crohn's disease: a double blind withdrawal trial","volume":"72","author":"O'Donoghue","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0013|cit14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(78)92524-2","article-title":"Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease","volume":"2","author":"O'Donoghue","year":"1978","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD000067.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1053\/j.gastro.2013.06.009","article-title":"Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease","volume":"145","author":"Pan\u00e9s","year":"2013","journal-title":"Gastroenterology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD000067.pub3-BIB0016|cit16","first-page":"S109","article-title":"Early use of azathioprine has a steroid sparing effect on recently diagnosed Crohn's disease patients","volume":"142","author":"Sans","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/BF01070829","article-title":"A controlled trial of azathioprine in Crohn's disease","volume":"20","author":"Rosenberg","year":"1975","journal-title":"American Journal of Digestive Diseases"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/0016-5085(79)90386-X","article-title":"National Cooperative Crohn's Disease Study: Adverse reactions to study drugs","volume":"77","author":"Singleton","year":"1979","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD000067.pub3-BIB0019|cit19","first-page":"A972","article-title":"National Cooperative Crohn's Disease Study (NCCDS): a controlled prospective trial of three drugs vs placebo","volume":"18","author":"Summers","year":"1977","journal-title":"Gut"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0016-5085(79)90385-8","article-title":"National Cooperative Crohn's Disease Study: results of drug treatment","volume":"77","author":"Summers","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S0140-6736(71)90268-6","article-title":"Controlled trial of azathioprine in Crohn's disease","volume":"2","author":"Willoughby","year":"1971","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD000067.pub3-BIB0022|cit22","first-page":"864","article-title":"A double-blind trial of azathioprine in Crohn's disease","volume":"12","author":"Willoughby","year":"1971","journal-title":"Gut"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0023|cit23","first-page":"569","article-title":"Azathioprine for prevention of postoperative recurrence in Crohn's disease","volume":"85","author":"Abdelli","year":"2007","journal-title":"Tunisie M\u00e9dicale"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1053\/j.gastro.2004.06.051","article-title":"Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.","volume":"127","author":"Ardizzone","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1016\/S1590-8658(12)60550-7","article-title":"Prevention of postoperative recurrence with azathioprine or anti-TNF alpha in patients with Crohn's disease: A pilot study","volume":"44","author":"Armuzzi","year":"2012","journal-title":"Digestive and Liver Disease"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD000067.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"S780","DOI":"10.1016\/S0016-5085(12)63025-X","article-title":"Prevention of postoperative recurrence with azathioprine or anti-TNF alpha in patients with Crohn's disease: An open-label pilot study","volume":"142","author":"Armuzzi","year":"2012","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD000067.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1016\/j.crohns.2013.04.020","article-title":"Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study","volume":"7","author":"Armuzzi","year":"2013","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1440-1746.2006.04393.x","article-title":"Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study","volume":"22","author":"Chebli","year":"2007","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"15","key":"10.1002\/14651858.CD000067.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","article-title":"Infliximab, azathioprine, or combination therapy for Crohn's disease","volume":"362","author":"Colombel","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(08)60304-9","article-title":"Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn\u2019s disease: an open randomised trial","volume":"371","author":"D\u2019Haens","year":"2008","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD000067.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1123-29","DOI":"10.1053\/j.gastro.2008.07.010","article-title":"Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn\u2019s disease: a controlled randomized trial","volume":"135","author":"D'Haens","year":"2008","journal-title":"Gastroenterology"},{"issue":"4 Suppl 2","key":"10.1002\/14651858.CD000067.pub3-BIB0032|cit32","first-page":"A52","article-title":"Combination therapy with metronidazole and azathioprine reduces severe postoperative recurrence of Crohn's disease: a double-blind controlled randomized trial","volume":"132","author":"D'Haens","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"716","DOI":"10.12659\/MSM.889196","article-title":"Effect of azathioprine or mesalazine therapy on incidence of re-hospitalization in sub-occlusive ileocecal Crohn's disease patients","volume":"19","author":"Souza","year":"2013","journal-title":"Medical Science Monitor"},{"issue":"3","key":"10.1002\/14651858.CD000067.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1053\/j.gastro.2004.06.002","article-title":"Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial","volume":"127","author":"Hanauer","year":"2004","journal-title":"Gastroenterology"},{"issue":"4 Suppl 2","key":"10.1002\/14651858.CD000067.pub3-BIB0035|cit35","first-page":"A480","article-title":"Double-blind, double dummy, randomized, multicentre, comparative study on the efficacy and safety of azathioprine (AZA) versus mesalazine (5-ASA) for prevention of postoperative endoscopic recurrence in Crohn's disease","volume":"130","author":"Herfarth","year":"2006","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD000067.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0016-5085(74)80166-6","article-title":"Treatment of Crohn's disease with azathioprine: a controlled evaluation","volume":"66","author":"Klein","year":"1974","journal-title":"Gastroenterology"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD000067.pub3-BIB0037|cit37","first-page":"A","article-title":"Post-operative prophylaxis with 6-MP, 5-ASA or placebo in Crohn\u2019s Disease: a 2 year multicenter trial","volume":"114","author":"Korelitz","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1053\/j.gastro.2006.02.014","article-title":"Infliximab plus azathioprine for steroid-dependent Crohn\u2019s disease patients: a randomized placebo-controlled trial","volume":"130","author":"L\u00e9mann","year":"2006","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD000067.pub3-BIB0039|cit39","first-page":"1889","article-title":"Addition of metronidazole to azathioprine for the prevention of postoperative recurrence of Crohn's disease: a randomized, double-blind, placebo-controlled trial","volume":"19","author":"Manosa","year":"2013","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S1873-9946(12)60230-X","article-title":"Azathioprine versus azathioprine plus metronidazole for the prevention of postoperative endoscopic recurrence of Crohn's disease: a randomized, placebo-controlled trial","volume":"6","author":"Manosa","year":"2012","journal-title":"Journal of Crohn's and Colitis"},{"issue":"1","key":"10.1002\/14651858.CD000067.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.crohns.2007.06.002","article-title":"The long-term efficacy of azathioprine does not wane after four years of continuous treatment in patients with steroid-dependent luminal Crohn's disease","volume":"1","author":"Mantzaris","year":"2007","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0042|cit42","first-page":"374","article-title":"Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease","volume":"23","author":"Nos","year":"2000","journal-title":"Gastroenterolog\u00eda y Hepatolog\u00eda"},{"issue":"12","key":"10.1002\/14651858.CD000067.pub3-BIB0043|cit43","first-page":"2203","article-title":"Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial","volume":"92","author":"Oren","year":"1997","journal-title":"American Journal of Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD000067.pub3-BIB0045|cit44","first-page":"147","article-title":"Treatment of Crohn's disease with 6-mercatopurine - a long-term, randomized, double-blind study","volume":"7","author":"Present","year":"1980","journal-title":"Innere Medizin"},{"issue":"18","key":"10.1002\/14651858.CD000067.pub3-BIB0044|cit45","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM198005013021801","article-title":"Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study","volume":"302","author":"Present","year":"1980","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1111\/j.1572-0241.2008.02024.x","article-title":"A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease","volume":"103","author":"Reinisch","year":"2008","journal-title":"American Journal of Gastroenterology"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD000067.pub3-BIB0047|cit47","first-page":"A","article-title":"A double-blind, double-dummy, randomized, controlled, multicenter trial on the efficacy and safety of azathioprine vs mesalamine for prevention of clinical relapses in Crohn's disease patients with postoperative moderate or severe endoscopic recurrence","volume":"134","author":"Reinisch","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/gut.2009.194159","article-title":"Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial","volume":"59","author":"Reinisch","year":"2010","journal-title":"Gut"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1016\/S1873-9946(13)60629-7","article-title":"Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in Crohn's disease patients with endoscopic recurrence: Follow-up data of a randomised, double-blind, double-dummy, 1-year, multicentre trial","volume":"7","author":"Reinisch","year":"2013","journal-title":"Journal of Crohn's and Colitis"},{"issue":"7683","key":"10.1002\/14651858.CD000067.pub3-BIB0051|cit50","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(70)92347-0","article-title":"Azathioprine in Crohn's disease","volume":"2","author":"Rhodes","year":"1970","journal-title":"Lancet"},{"issue":"7737","key":"10.1002\/14651858.CD000067.pub3-BIB0050|cit51","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(71)90598-8","article-title":"Controlled trial of azathioprine in Crohn's disease","volume":"2","author":"Rhodes","year":"1971","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD000067.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/ajg.2013.287","article-title":"Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial","volume":"108","author":"Savarino","year":"2013","journal-title":"The American journal of gastroenterology"},{"issue":"4 Suppl 2","key":"10.1002\/14651858.CD000067.pub3-BIB0053|cit53","first-page":"A113","article-title":"Azathioprine withdrawal in patients with Crohn's disease (CD) maintained on prolonged remission under treatment is associated with a high risk of relapse","volume":"126","author":"Treton","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD000067.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cgh.2008.08.028","article-title":"Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse","volume":"7","author":"Treton","year":"2009","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"7","key":"10.1002\/14651858.CD000067.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1053\/j.gastro.2008.03.004","article-title":"Withdrawal of immunosuppression in crohn\u2019s disease treated with scheduled infliximab maintenance: A randomized trial","volume":"134","author":"Assche","year":"2008","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD000067.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1365-2036.2004.01944.x","article-title":"Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn's disease: increased relapse rate the following year","volume":"19","author":"Vilien","year":"2004","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0057|cit57","first-page":"796","article-title":"Azathioprine in management of Crohn's disease: a randomized cross-over study","volume":"66","author":"Watson","year":"1974","journal-title":"Gastroenterology"},{"issue":"Suppl 10","key":"10.1002\/14651858.CD000067.pub3-BIB0058|cit58","first-page":"A1193","article-title":"Azathioprine and levamisole in Crohn's disease: a double blind controlled trial of one year's treatment with long follow up","volume":"31","author":"Willoughby","year":"1990","journal-title":"Gut"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD000067.pub3-BIB0059|cit59","first-page":"A116","article-title":"Excess risk of lymphoproliferative disorders (Lpd) in inflammatory bowel diseases (IBD): Interim results of the Cesame cohort","volume":"134","author":"Beaugerie","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"439-44","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD000067.pub3-BIB0061|cit61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000545.pub4","article-title":"Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease","author":"Chande","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD000067.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1542-3565(04)00344-1","article-title":"Azathioprine, 6-mercaptopurine in inflammatory bowel disease: Pharmacology, efficacy, and safety","volume":"2","author":"Dubinsky","year":"2004","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0063|cit63","unstructured":"Dyer N Studies on Crohn's disease MD Thesis University of Cambridge 1970"},{"issue":"8","key":"10.1002\/14651858.CD000067.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/pds.926","article-title":"Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease","volume":"13","author":"Gearry","year":"2004","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"8","key":"10.1002\/14651858.CD000067.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1440-1746.2005.03832.x","article-title":"Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease","volume":"20","author":"Gearry","year":"2005","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"8","key":"10.1002\/14651858.CD000067.pub3-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010233.pub2","article-title":"Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease","author":"Gordon","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7650","key":"10.1002\/14651858.CD000067.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD000067.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S1542-3565(04)00238-1","article-title":"Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease","volume":"2","author":"Hanauer","year":"2004","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0069|cit69","article-title":"Chapter 8: Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Higgins","year":"2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0070|cit70","article-title":"Chapter 16: Special topics in statistics","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Higgins","year":"2011. Available from www.cochrane-handbook.org"},{"issue":"8","key":"10.1002\/14651858.CD000067.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2004.049460","article-title":"Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine","volume":"54","author":"Kandiel","year":"2005","journal-title":"Gut"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0072|cit72","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases A multi-site trial of azathioprine dosing in Crohn's disease ClinicalTrials.gov, NCT00113503, 2008"},{"issue":"8","key":"10.1002\/14651858.CD000067.pub3-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006884.pub3","article-title":"Methotrexate for maintenance of remission in Crohn\u2019s disease","author":"Patel","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(70)92347-0","article-title":"Azathioprine in Crohn's disease","volume":"2","author":"Rhodes","year":"1970","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00228-008-0478-6","article-title":"Clinical pharmacology and pharmacogenetics of thiopurines","volume":"64","author":"Sahasranaman","year":"2008","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0076|cit76","article-title":"Chapter 12: Interpreting results and drawing conclusions","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Sch\u00fcnemann","year":"2011. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD000067.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"132","DOI":"10.7326\/0003-4819-123-2-199507150-00009","article-title":"Azathioprine and 6-mercaptopurine in Crohn disease: a meta-analysis","volume":"122","author":"Pearson","year":"1995","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD000067.pub3-BIB0078|cit78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000067","article-title":"Azathioprine for maintenance of remission in Crohn's disease","author":"Pearson","year":"1998","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD000067.pub3-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000067.pub2","article-title":"Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn\u2019s disease","author":"Prefontaine","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD000067.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T14:34:09Z","timestamp":1666103649000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD000067.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane IBD Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,30]]},"references-count":79,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000067.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,30]]}}}